Tag: Eluting
India coronary stent market set for 4% CAGR growth during 2024-2033,...
India’s coronary drug eluting stent market accounts for around 32% of the Asia-Pacific market in 2024
Terumo India advances treatment options for heart disease with launch of...
Ultimaster Nagomi™, by Terumo India, is one such new generation Drug-Eluting Stent that can facilitate smooth navigation to complex arteries and adapt to any vessel size with ease
Drug-coated balloons is an alternative to stents in younger patients, say...
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
NPPA’s green signal to bioresorbable stent by Meril Life Sciences for...
An extensively researched innovation, MeRes100 BRS is backed by 3-year efficacy and safety clinical trial data, has received 8 patents worldwide, CE mark approval and a DCGI granted 122E new drug approval that attests to its efficacy and safety for the indicated use.....................
BioVoice eMag September 2016 Issue-5 Volume-1
BioVoice eMag September 2016 Issue-5 Volume-1:
This edition of BioVoice is mostly focused on healthcare policy in India. The detailed cover story analyses the importance...